43406-0696 NDC - FCS HP (EPINEPHRINE,GLUTAMICACID,MUCUNAPRURIENSSEED,NIACINAMIDE,SEROTONIN,UBIDECARENONE,CORTICOTROPIN,ADENOSINETRIPHOSPHATE,INSULINPORK,SUSSCROFAPARATHYROIDGLAND,SUSSCROFAPITUITARYGLAND,THIAMINEHYDROCHLORIDE,THYROID,ANHYDROUSCITRICACID,HERRINGSPERMDNA,SACCHAROMYCESCEREVISIAERNA,ANACARDIUMOCCIDENTALEFRUIT,ARSENICTRIOXIDE,ASPARTICACID,BARIUMCARBONATE,OYSTERSHELLCALCIUMCARBONATECRUDE,CLEMATISRECTAFLOWERINGTOP,LYCOPODIUMCLAVATUMSPORE,ANEMONEPULSATILLA,DATURASTRAMONIUM,SULFUR)

Drug Information

  • Product NDC: 43406-0696
  • Proprietary Name: FCS HP
  • Non Proprietary Name: Epinephrine,GlutamicAcid,MucunaPruriensSeed,Niacinamide,Serotonin,Ubidecarenone,Corticotropin,AdenosineTriphosphate,InsulinPork,SusScrofaParathyroidGland,SusScrofaPituitaryGland,ThiamineHydrochloride,Thyroid,AnhydrousCitricAcid,HerringSpermDNA,SaccharomycesCerevisiaeRNA,AnacardiumOccidentaleFruit,ArsenicTrioxide,AsparticAcid,BariumCarbonate,OysterShellCalciumCarbonateCrude,ClematisRectaFloweringTop,LycopodiumClavatumSpore,AnemonePulsatilla,DaturaStramonium,Sulfur
  • Active Ingredient(s): 6 [hp_C]/mL ADENOSINE TRIPHOSPHATE; 30 [hp_C]/mL ANACARDIUM OCCIDENTALE FRUIT; 30 [hp_C]/mL ANEMONE PULSATILLA; 12 [hp_C]/mL ANHYDROUS CITRIC ACID; 30 [hp_C]/mL ARSENIC TRIOXIDE; 30 [hp_C]/mL ASPARTIC ACID; 30 [hp_C]/mL BARIUM CARBONATE; 30 [hp_C]/mL CLEMATIS RECTA FLOWERING TOP; 30 [hp_C]/mL CORTICOTROPIN; 30 [hp_C]/mL DATURA STRAMONIUM; 30 [hp_C]/mL EPINEPHRINE; 30 [hp_C]/mL GLUTAMIC ACID; 12 [hp_C]/mL HERRING SPERM DNA; 6 [hp_C]/mL INSULIN PORK; 30 [hp_C]/mL LYCOPODIUM CLAVATUM SPORE; 30 [hp_C]/mL MUCUNA PRURIENS SEED; 9 [hp_X]/mL NIACINAMIDE; 30 [hp_C]/mL OYSTER SHELL CALCIUM CARBONATE, CRUDE; 12 [hp_C]/mL SACCHAROMYCES CEREVISIAE RNA; 30 [hp_C]/mL SEROTONIN; 30 [hp_C]/mL SULFUR; 6 [hp_C]/mL SUS SCROFA PARATHYROID GLAND; 6 [hp_C]/mL SUS SCROFA PITUITARY GLAND; 6 [hp_C]/mL THIAMINE HYDROCHLORIDE; 6 [hp_C]/mL THYROID, UNSPECIFIED; 9 [hp_X]/mL UBIDECARENONE
  • Administration Route(s): ORAL
  • Dosage Form(s): LIQUID
  • Pharmacy Class(es): Acidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Catecholamine [EPC]; Catecholamines [CS]; Decreased Coagulation Factor Activity [PE]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]

Labeler Information

Field Name Field Value
Labeler Name: Natural Creations, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:6/1/2018

Package Information

No. Package Code Package Description Billing Unit
143406-0696-130 mL in 1 BOTTLE, DROPPER (43406-0696-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC43406-0696The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEFCS HPThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEEpinephrine,GlutamicAcid,MucunaPruriensSeed,Niacinamide,Serotonin,Ubidecarenone,Corticotropin,AdenosineTriphosphate,InsulinPork,SusScrofaParathyroidGland,SusScrofaPituitaryGland,ThiamineHydrochloride,Thyroid,AnhydrousCitricAcid,HerringSpermDNA,SaccharomycesCerevisiaeRNA,AnacardiumOccidentaleFruit,ArsenicTrioxide,AsparticAcid,BariumCarbonate,OysterShellCalciumCarbonateCrude,ClematisRectaFloweringTop,LycopodiumClavatumSpore,AnemonePulsatilla,DaturaStramonium,SulfurThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE6/1/2018This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMENatural Creations, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEADENOSINE TRIPHOSPHATE; ANACARDIUM OCCIDENTALE FRUIT; ANEMONE PULSATILLA; ANHYDROUS CITRIC ACID; ARSENIC TRIOXIDE; ASPARTIC ACID; BARIUM CARBONATE; CLEMATIS RECTA FLOWERING TOP; CORTICOTROPIN; DATURA STRAMONIUM; EPINEPHRINE; GLUTAMIC ACID; HERRING SPERM DNA; INSULIN PORK; LYCOPODIUM CLAVATUM SPORE; MUCUNA PRURIENS SEED; NIACINAMIDE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; SACCHAROMYCES CEREVISIAE RNA; SEROTONIN; SULFUR; SUS SCROFA PARATHYROID GLAND; SUS SCROFA PITUITARY GLAND; THIAMINE HYDROCHLORIDE; THYROID, UNSPECIFIED; UBIDECARENONEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH6; 30; 30; 12; 30; 30; 30; 30; 30; 30; 30; 30; 12; 6; 30; 30; 9; 30; 12; 30; 30; 6; 6; 6; 6; 9 
ACTIVE INGRED UNIT[hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL 
PHARM CLASSESAcidifying Activity [MoA], Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Catecholamine [EPC], Catecholamines [CS], Decreased Coagulation Factor Activity [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 6/6/2025

Previous Code
Next Code